lymphocyte depleted Hodgkin lymphoma

同

LDHL

WordNet

1. English physiologist who, with Andrew Huxley, discovered the role of potassium and sodium atoms in the transmission of the nerve impulse (1914-1998) (同)Alan Hodgkin, Sir Alan Hodgkin, Alan Lloyd Hodgkin
2. English chemist (born in Egypt) who used crystallography to study the structure of organic compounds (1910-1994) (同)Dorothy Hodgkin, Dorothy Mary Crowfoot Hodgkin
3. English physician who first described Hodgkins disease (1798-1866) (同)Thomas Hodgkin
4. an agranulocytic leukocyte that normally makes up a quarter of the white blood cell count but increases in the presence of infection (同)lymph cell
5. a neoplasm of lymph tissue that is usually malignant; one of the four major types of cancer
6. no longer sufficient; "supplies are low"; "our funds are depleted" (同)low

PrepTutorEJDIC

1. 〈価値・分量・内容など〉‘を'激減させる,使い果たす

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 古典型ホジキンリンパ腫の疫学、病理学的特徴、および診断 epidemiology pathologic features and diagnosis of classical hodgkin lymphoma
• 2. 成人における古典型ホジキンリンパ腫の臨床症状および疾患分布のパターン clinical presentation and patterns of disease distribution in classical hodgkin lymphoma in adults
• 3. ホジキンリンパ腫におけるエプスタイン・バール・ウイルス the role of epstein barr virus in hodgkin lymphoma
• 4. HIV感染と悪性腫瘍：マネージメント上の考慮事項 hiv infection and malignancy management considerations
• 5. 小児および思春期におけるホジキンリンパ腫の概要 overview of hodgkin lymphoma in children and adolescents

English Journal

• KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.

• Carbone A1, De Paoli P2, Gloghini A3, Vaccher E4.
• International journal of cancer. Journal international du cancer.Int J Cancer.2015 Jul 15;137(2):251-61. doi: 10.1002/ijc.28923. Epub 2014 May 5.
• Multicentric Castleman Disease (MCD) is a lymphoproliferative disorder presenting with heterogeneous pathological and clinical features. It comprises disease entities with a complex aetiology and overlapping pathogenesis. MCD can be found in association with HIV infection, plasma-cell dyscrasias, Ka
• PMID 24771491

• Clinical development of siltuximab.

• Davis CC1, Shah KS, Lechowicz MJ.
• Current oncology reports.Curr Oncol Rep.2015 Jul;17(7):453. doi: 10.1007/s11912-015-0453-1.
• Siltuximab is a chimeric monoclonal antibody targeting interleukin-6 (IL-6), which in the fall of 2014 became the first FDA-approved treatment of the rare disease idiopathic multicentric Castleman's disease (MCD). MCD is a non-clonal lymphoproliferative disorder in which common symptoms include feve
• PMID 25986720

• Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry.

• Husson O1, Mols F, van de Poll-Franse L, de Vries J, Schep G, Thong MS.
• Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.Support Care Cancer.2015 Jul;23(7):2165-74. doi: 10.1007/s00520-014-2577-5. Epub 2015 Jan 6.
• PURPOSE: Cancer survivors commonly experience fatigue, related to disease and its treatment. This study aimed to compare fatigue severity among survivors of different cancer types with a normative population and also to identify variations in fatigue among cancer survivors according to clinical and
• PMID 25556703

Japanese Journal

• Discordant lymphocyte-depketed classical Hodgkin's and peripheral T-cell lymphoma arising in a patient 11 years after deagnosis of multicentric Castleman's disease

• PARK Joonhong,LEE Ji Eun,KIM Myungshin,LIM Jihyang,KIM Yonggoo,HAN Kyungja,PARK Gyeongsin,JUNG Young Hee,ROH Sang Young,HONG Young Seon
• International journal of hematology 98(1), 114-121, 2013-07-01
• NAID 10031189604

• Lymphocyte-depleted Hodgkin Lymphoma Complicating Hemophagocytic Lymphohistiocytosis as an Initial Manifestation: A Case Report and Review of the Literature

• Hagihara Masao,Inoue Morihiro,Hua Jian,Iwaki Yasunobu
• Internal Medicine 51(21), 3067-3072, 2012
• … Hemophagocytic lymphohistocytosis (HLH) is commonly associated with infectious diseases or T/NK cell-lymphoma; … however that with Hodgkin lymphoma (HL) was rarely reported. … Herein, we describe a young male diagnosed with lymphocyte-depleted HL (LD-HL) complicated by HLH as an initial manifestation. …
• NAID 130002061963

• 抗CD20抗体がB細胞を除去する分子機構について

• 濱口 儒人
• 日本臨床免疫学会会誌 = Japanese journal of clinical immunology 32(1), 29-34, 2009-02-28
•   CD20はB細胞に特異的に発現している膜表面分子であり，抗ヒトCD20ヒト・マウスキメラ抗体（リツキシマブ）はB細胞由来悪性リンパ腫に有効性が示されている．また，近年B細胞の自己免疫疾患，炎症性疾患への関与を示唆する報告が相次ぎ，B細胞が治療ターゲットとして注目を集めていることから，CD20抗体療法はこれらの疾患へも応用が試みられている．しかしながら，抗CD20抗体が生体内でB細胞を除去する分 …
• NAID 10024961842

Related Links

• Lymphocyte Depleted Hodgkin's Lymphoma - Types of ...

Lymphocyte-depleted Hodgkin’s lymphoma is a type of Hodgkin’s disease, a cancer of lymph cells . It is the least common of the types of Hodgkin’s disease, comprising only 1% of all cases of this cancer. It is more common in the ...

• Hodgkin's Disease Lymphoma - Lymphocyte Depleted ...

Lymphocyte-depleted Hodgkin’s lymphoma is a type of Hodgkin’s disease, a cancer of lymph cells. It is the least common of the types of Hodgkin’s disease, comprising only 1% of all cases of this cancer. It is more ...

---

★リンクテーブル★

リンク元	「LDHL」
関連記事	「lymphocyte」「deplete」

「LDHL」

　　[★]

同

lymphocyte depleted Hodgkin lymphoma

「lymphocyte」

　　[★] リンパ球

同

lymphocytes＆development

　

「deplete」

　　[★]

• 枯渇させる

関

depletion